MANNELLI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 19.805
EU - Europa 11.143
AS - Asia 7.056
SA - Sud America 1.097
Continente sconosciuto - Info sul continente non disponibili 244
AF - Africa 204
OC - Oceania 147
Totale 39.696
Nazione #
US - Stati Uniti d'America 19.492
RU - Federazione Russa 3.428
IT - Italia 2.282
SG - Singapore 1.915
PL - Polonia 1.646
CN - Cina 1.510
HK - Hong Kong 1.229
SE - Svezia 884
IE - Irlanda 863
VN - Vietnam 854
BR - Brasile 846
KR - Corea 617
DE - Germania 459
UA - Ucraina 395
FI - Finlandia 319
FR - Francia 318
IN - India 253
GB - Regno Unito 231
CA - Canada 181
BD - Bangladesh 156
AU - Australia 141
JO - Giordania 115
AR - Argentina 100
CH - Svizzera 89
ID - Indonesia 68
NL - Olanda 67
TR - Turchia 63
JP - Giappone 61
EC - Ecuador 52
IQ - Iraq 46
MX - Messico 44
ES - Italia 41
CI - Costa d'Avorio 35
BE - Belgio 33
NG - Nigeria 33
ZA - Sudafrica 33
CO - Colombia 31
VE - Venezuela 25
CR - Costa Rica 23
AT - Austria 22
PK - Pakistan 21
MA - Marocco 19
PY - Paraguay 18
SC - Seychelles 16
PH - Filippine 15
MY - Malesia 14
SA - Arabia Saudita 14
EG - Egitto 13
HN - Honduras 13
NP - Nepal 13
CZ - Repubblica Ceca 12
DZ - Algeria 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
JM - Giamaica 11
TN - Tunisia 11
LT - Lituania 9
KE - Kenya 8
AL - Albania 7
AZ - Azerbaigian 7
KG - Kirghizistan 7
NI - Nicaragua 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
IL - Israele 6
NZ - Nuova Zelanda 6
PE - Perù 6
AM - Armenia 5
BG - Bulgaria 5
BJ - Benin 5
DO - Repubblica Dominicana 5
GE - Georgia 5
HU - Ungheria 5
PR - Porto Rico 5
RO - Romania 5
BY - Bielorussia 4
KZ - Kazakistan 4
OM - Oman 4
SN - Senegal 4
TH - Thailandia 4
AO - Angola 3
BN - Brunei Darussalam 3
BS - Bahamas 3
EU - Europa 3
GR - Grecia 3
MD - Moldavia 3
MU - Mauritius 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
BZ - Belize 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
GT - Guatemala 2
KW - Kuwait 2
MK - Macedonia 2
PA - Panama 2
Totale 39.425
Città #
Santa Clara 2.594
Ashburn 2.045
Fairfield 1.963
Warsaw 1.640
Singapore 1.383
Hong Kong 1.021
Woodbridge 937
Chandler 863
Dublin 861
Seattle 796
Cambridge 782
San Jose 736
Dallas 726
Houston 716
Jacksonville 642
Wilmington 626
Seoul 612
Milan 499
Ann Arbor 362
Beijing 353
Council Bluffs 352
Princeton 261
Lawrence 254
Ho Chi Minh City 251
Hefei 243
Los Angeles 241
Altamura 231
Buffalo 230
Lauterbourg 204
The Dalles 198
Hanoi 188
Rome 187
Florence 184
Boston 167
Moscow 165
Boardman 160
Mumbai 157
Melbourne 137
New York 123
Medford 122
Munich 112
San Diego 101
Shanghai 86
Bern 84
Phoenix 84
Helsinki 64
West Jordan 62
Naples 60
Dong Ket 59
Bologna 58
Chicago 56
São Paulo 56
Paris 54
Tokyo 53
Columbus 51
Turku 51
Kent 49
Clifton 48
Redondo Beach 46
Toronto 46
Jakarta 45
Turin 45
Norwalk 42
Amsterdam 41
Haiphong 40
Brooklyn 38
Falls Church 36
Abidjan 35
Izmir 35
Brussels 32
Da Nang 32
London 31
Orem 31
Hillsboro 30
Montreal 30
Abuja 29
Frankfurt am Main 28
Rio de Janeiro 27
Figino 26
Palermo 24
Guangzhou 23
Philadelphia 23
Andover 22
Atlanta 22
Voghera 22
Yubileyny 22
Chennai 20
Johannesburg 20
San Francisco 20
Venice 20
Baghdad 19
Denver 19
Pune 19
San José 19
Bari 18
Belo Horizonte 18
Genoa 18
Hải Dương 18
Prato 18
Vienna 18
Totale 26.567
Nome #
(0) Save to: more options SPECT semiquantitative analysis of adrenocortical. I-131-6 beta-iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma 1.360
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 364
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 360
Incidental and metastatic adrenal masses 354
Seladin-1 expression is regulated by promoter methylation inadrenal cancer 331
Metformin as a new anti-cancer drug in adrenocortical carcinoma 321
Feasibility and safety of minimal-incision thyroidectomy for Graves' disease: A prospective, single-center study 311
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 308
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 300
Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. 297
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. 297
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 293
The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model 258
A case of malignant insulinoma responsive to somatostatin analogs treatment 257
A unique neuroendocrine cell model derived from the human foetal neural crest. 244
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma 240
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas. 238
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 237
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 237
Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. 232
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 230
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells. 225
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 223
A case of hyponatremia caused by central hypocortisolism 221
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA 218
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 216
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 216
Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts 211
Il dosaggio delle metanefrine nella diagnosi del feocromocitoma: vantaggi clinici e problematiche di laboratorio 207
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 204
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 202
Rare diseases in clinical endocrinology: a taxonomic classification system. 201
Adrenal incidentaloma: the influence of a decision-making algorithm on the short-term outcome of laparoscopy 200
Clinical impact of the new SIAPEC-IAP classification on the indeterminate category of thyroid nodules 199
A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case. 198
A study on human adrenal secretion. Measurement of epinephrine, norepinephrine, dopamine and cortisol in peripheral and adrenal venous blood under surgical stress. 196
Analysis of circulating microRNAs in adrenocortical tumors. 196
Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study 195
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. 193
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 193
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 192
Genetic screening for pheochromocytoma: should SDHC gene analysis be included? 191
Effects of prostaglandin E2 inhibition on norepinephrine plasma levels after adrenergic stimulation in man. 191
Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. 191
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations 190
A further case of giant intrasellar carotid aneurysm mimicking a pituitary adenoma: the relevance of a multivariate approach in differential diagnosis. 190
Effects of thyroid replacement therapy on catecholamine plasma levels. 189
SDH mutations in patients affected by paraganglioma syndromes: a personal experience. 189
Adrenal medulla secretion in Cushing's syndrome. 189
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 189
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. 188
Cushing's syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection 187
Phenotype variability of neural crest-derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. 187
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 187
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma 185
Novel Somatic Mutations in the Catalytic Subunit of the Protein Kinase A as a Cause of Adrenal Cushing's Syndrome: A European Multicentric Study. 185
The role of metabolic changes in shaping the fate of cancer-associated adipose stem cells 184
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 184
Pheochromocytoma in Italy: a multicentric retrospective study. 183
Presence and distribution of endothelin-1 gene expression in human kidney. 183
Caratterizzazione genomica del carcinoma surrenalico 183
Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. 182
Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture 182
Localization of endothelin-converting enzyme-1 in human kidney 181
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 180
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 179
Measurement of catecholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas. 179
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 178
A prospective study of the prevelence of primary aldosteronism in 1,125 hypertensive patients 177
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 177
Adjuvant mitotane treatment for adrenocortical carcinoma 176
[Peripheral dopamine DA1-type receptors: their localization, functional role and possible clinical implications] 175
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 175
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? 174
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment 173
Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer 173
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 172
Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function 172
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 171
Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. 171
Handgrip-induced airway dilation in asthmatic patients with bronchoconstriction induced by MCh inhalation. 171
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 171
Integrated genomic characterization of adrenocortical carcinoma. 170
SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism 170
False serum calcitonin high levels using a non-competitive two-site IRMA. 169
Clinical relevance of phenotype/genotype correlations in the diagnosis and therapy of pheochromocytomas/paragangliomas. 169
Antitumor effect and interaction with ionizing radiation of PPAR_GAMMA on adrenocortical carcinoma 168
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. 167
Functional significance of germline EPAS1 variants 167
[Diagnostic problems in pheochromocytoma] 166
DNA methylation is an independent prognostic marker of survival in adrenocortical cancer 166
Ipertensione ed esercizio fisico 166
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 166
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 166
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma 166
Measurement of Cortisol to Cortisone ratio in human urine and saliva by LC-MS/MS 166
Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or non-functional paragangliomas. 165
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. 164
Prognostic and monitoring value of circulating tumour cells in adrenocortical carcinoma: a preliminary monocentric study. 164
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling. 164
Totale 21.608
Categoria #
all - tutte 108.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.400 0 0 119 69 72 94 54 120 95 93 256 428
2022/20233.928 418 695 179 278 317 718 497 184 380 29 121 112
2023/20241.381 65 156 252 79 98 166 35 241 27 122 92 48
2024/20258.711 344 1.043 596 1.480 2.342 865 151 624 419 221 312 314
2025/202611.666 1.126 1.713 1.260 939 1.114 414 1.291 581 690 651 275 1.612
2026/20271.700 322 389 989 0 0 0 0 0 0 0 0 0
Totale 39.696